Bank of America Merrill Lynch exec to join NAB

The incoming head of finance and strategy may become a contender for the bank's top job.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The market responded positively to National Australia Bank's (ASX: NAB) plan to bring Bank of America Merrill Lynch chief executive and country head Craig Drummond down under, to take charge of the finance and strategy role of the company.

Mr Drummond told The Australian "I feel very good about being able to leave Bank of America Merrill Lynch at a time when it's in very good shape". Although he won't be receiving a position on the board, many believe he could be the successor of current CEO Cameron Clyne.

Mr Drummond must also forfeit over $6.5 million in deferred employment incentives from his current employer. However, NAB has said it will compensate him in cash and equity.

Other possible new bosses include Gavin Slater, head of personal banking, Lisa Gray, head of operations, and Joseph Healy, who is in charge of the nation's biggest business bank. Although Mr Clyne would rather an internal appointment of the new CEO, the strategy to appoint a new chief rests solely with him.

Bringing in an external leader could also be good for the bank. It'll provide the newcomer with an opportunity to transform the bank and rid it of a history of underperformance. Mr Clyne said that Drummond, former chief operating officer of Goldman Sachs JBWere, would be a "strong addition to our leadership team".

Foolish takeaway

NAB could do with a transformation of its business, and perhaps an experienced outsider can bring something new to Australia's fourth biggest bank. Compared to the Commonwealth Bank (ASX: CBA) and ANZ (ASX: NAB) NAB is not as appealing to investors, particularly when you take into account its accident-prone history. With little growth on the cards, NAB is fully priced or perhaps even a little overpriced although its 9.0% (once franked) dividend is very appealing to income investors.

Interested in our #1 dividend-paying stock? Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

More reading


Motley Fool contributor Owen Raszkiewicz owns shares in ANZ.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »